<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rhynchophylline (Rhy) inhibited rabbit platelet aggregation induced by <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> (AA), collagen, and <z:chebi fb="13" ids="16761">ADP</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The values of IC50 were 0.72, 0.74, and 0.67 mmol.L-1, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Rhy reduced the <z:chebi fb="0" ids="28728">thromboxane B2</z:chebi> (<z:chebi fb="0" ids="28728">TXB2</z:chebi>) generation in PRP induced by collagen but failed to reduce that induced by AA </plain></SENT>
<SENT sid="3" pm="."><plain>Rhy suppressed malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) formation in platelet suspension stimulated by thrombin, inhibited the platelet factor 4 (<z:chebi fb="0" ids="30203">PF4</z:chebi>) release </plain></SENT>
<SENT sid="4" pm="."><plain>It did not alter intraplatelet cAMP concentration </plain></SENT>
<SENT sid="5" pm="."><plain>Rhy 10-20 mg.kg-1 iv showed a significant inhibition of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> in rats </plain></SENT>
</text></document>